Antiprotozoal effect of steroid hormone 20-hydroxyecdysone in giardiosis patients.

The World Health Organization reports that approximately 200 million people are infected with Giardia (G.) lamblia worldwide. Taking into account the emergence of resistance and the high toxicity of conventional drugs, research into new strategies to fight against G. lamblia is increasing. The aim of the study was to assess the antiprotozoal activity of 20-hydroxyecdysone in water sports athletes with giardiosis. A randomized, double-blinded, placebocontrolled clinical study was conducted. Seventy-six athletes with G. lamblia infection participated in the study and were divided into 20-hydroxyecdysone, metronidazole and placebo groups. Clinical, parasitological, haematological and biochemical analyses were performed. Positive results for antiprotozoal therapy were revealed in the 20-hydroxyecdysone and metronidazole groups. After therapy, elimination of G. lamblia was observed in 100.0% of the athletes included in the 20-hydroxyecdysone group. However, G. lamblia was resistant to metronidazole in 4.0% of athletes included in the metronidazole group. A positive clinical response to the therapy occurred in the 20-hydroxyecdysone and metronidazole groups. Our study reveals high antiprotozoal activity of 20-hydroxyecdysone against G. lamblia. Further clinical studies are necessary to evaluate the antiprotozoal efficacy of 20-hydroxyecdysone.

Pityriasis alba: Possible associations with intestinal helminths and pathogenic protozoa.

BACKGROUND: The aetiology of pityriasis alba (PA) remains uncertain, and children are at risk for PA and intestinal parasites. AIM: To determine the prevalence of intestinal parasites in PA patients and to evaluate their possible role in PA pathogenesis. METHODS: Overall, 180 PA patients and 100 healthy individuals were enrolled. Intestinal parasites were diagnosed by triple coproscopy, and the total serum Immunoglobulin E (IgE) levels were determined by ELISA. PA patients with intestinal parasites were treated with conventional antiparasitic drugs. Patient response to antiparasitic therapy was evaluated after 6 weeks. RESULTS: The prevalence of intestinal parasites in PA patients and controls was 60 ± 3.6% and 32 ± 4.6%, respectively (P < .0001). Regardless of the parasite species among the PA patients and control individuals, the total IgE levels were significantly higher in PA patients (P ≤ .05). The highest values of IgE were found in PA patients with Hymenolepis nana (641.7 ± 46.3 IU/mL). The total IgE level in PA patients with parasites decreased after antiparasitic therapy, but the reduction was only significant in patients with H. nana (P < .05). Complete disappearance of hypopigmented patches was observed after the elimination of H. nana, Giardia lamblia and Enterobius vermicularis in 65 ± 10.6%, 48.7 ± 8.0% and 33.3 ± 8.2% of cases, respectively. In total, a positive clinical response to antiparasitic therapy was achieved in 60 ± 4.7% of infected PA patients. CONCLUSION: A positive clinical response to antiparasitic therapy indicates the role of intestinal parasites in PA pathogenesis. Parasitological examination is justified by the recovery of 60 ± 4.7% of infected PA patients after the elimination of intestinal parasites.